tirzepatide news november 2025 In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL New Tirzepatide Access and Pricing

This occurs regardless of whether or not the patient gets thyroid hormone replacement after these therapies (which is also concerning)

Further studies include REDEFINE 3 (heart benefits vs placebo in adults with heart disease) and REDEFINE 4 (84-week head-to-head vs tirzepatide 15 mg)

Microdosing GLP-1 Medications in Charleston GLP-1 medications such as semaglutide and tirzepatide have skyrocketed in popularity in a relatively short time and are reshaping the treatment of obesity and metabolic disease

Major medical organizations including the American Medical Association and American Heart Association recognize obesity as a chronic disease requiring pharmacologic treatment, yet many BCBS plans have not updated their policies accordingly